Actively Recruiting
Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong - the HONG KONG PECT Registry
Led by Chinese University of Hong Kong · Updated on 2025-06-19
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
C
Chinese University of Hong Kong
Lead Sponsor
C
China Medical University, Taiwan
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are comparing different catheter-based treatments for patients with acute pulmonary embolism (PE), a serious condition that can worsen quickly and cause death without timely care. The study focuses on two main types of catheter therapies: catheter-directed thrombolysis, which uses medication to dissolve clots, and aspiration thrombectomy, which physically removes clots. The goal is to evaluate how these treatments differ in safety, effectiveness, and clinical outcomes using data from patients treated in Hong Kong hospitals. The treatments being compared include catheter-directed thrombolysis methods like ultrasound-assisted EKOS, and aspiration thrombectomy devices such as Penumbra, Flowtriever, and AlphaVac. This retrospective study collects past patient data from January 2016 to December 2021 to analyze outcomes after these procedures. Since this is a registry study, no new treatments are given; instead, existing clinical records are reviewed to understand the impacts of these therapies. Participants' medical records are examined to measure outcomes including mortality during hospital stay, complications within 72 hours post-procedure, changes in heart and lung function, bleeding events, and longer-term mortality up to 90 days. The study ensures privacy by removing identifying details and securely storing data. The total participation involves data collection and analysis without active patient involvement, covering treatment outcomes during hospital stay and follow-up periods.
CONDITIONS
Brief Title
Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who is admitted with a diagnosis of acute pulmonary embolism
- Patient who receives any types of catheter-based therapy for acute pulmonary embolism
You will not qualify if you...
- None; this is an all-comer registry.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Data collection is retrospective from existing medical records; no visits are required for participants.
Duration - Hospital stay of approximately 7 days
Participants undergo catheter-based therapy for acute pulmonary embolism, including catheter-directed thrombolysis or aspiration thrombectomy.
Participants receive treatment during inpatient hospitalization.
Duration - Up to 90 days after treatment
Participants are monitored for procedural complications, changes in clinical parameters, and mortality outcomes after catheter-based therapy.
Follow-up assessments include clinical evaluations up to 90 days post-procedure.
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong, Hong Kong, 0000
Actively Recruiting
Research Team
G
GuangMing Tan
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here